CADLBiotechnology / Biotechnology
Candel Therapeutics Inc
30-Day Price
Key Metrics
Latest Close
$4.97
Market Cap
$360M
Shares Outstanding
73,250,000
P/B Ratio
5.97
ROE
-8319.00%
ROA
-5163.00%
Operating Margin
-2800081.00%
Net Margin
-1515645.00%
Debt / Equity
0.91
Current Ratio
13.49
Want the full picture?
Sign up free for full analysis, strategy backtesting with credibility scoring, portfolio management, and more.
Start Free